XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Common Shares
Class A Common Shares
Common Shares
Class B Common Shares
Preferred Shares
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Distributions in Excess of Net Income
Total Shareholders' Equity
Noncontrolling Interest
Common Shares
Total Equity
Beginning Balance at Dec. 31, 2020 $ 0                    
Ending Balance at Mar. 31, 2021 0                    
Balance at Dec. 31, 2020     $ 389 $ 0 $ 147 $ 1,150,985 $ (19,275) $ (509,243) $ 623,003 $ 49,246 $ 672,249
Balance (in shares) at Dec. 31, 2020   38,843,482     14,703,214         5,392,808  
Increase (Decrease) in Stockholders' Equity                      
Unit Conversion     2     2,870     2,872 $ (2,872)  
Unit Conversion (in shares)   225,000               (225,000)  
Dividends and Distributions declared:                      
Preferred Shares               (30,218) (30,218)   (30,218)
Share Based Compensation:                      
Grants           (9)     (9) $ 1,614 1,605
Grants (in shares)   63,825               775,206  
Amortization           733     733 $ 862 1,595
Change in Fair Value of Derivative Instruments 6,766           6,766   6,766   6,766
Net (loss) income 9,090             8,926 8,926 322 9,248
Balance at Mar. 31, 2021     391 0 $ 147 1,154,579 (12,509) (530,535) 612,073 $ 49,172 661,245
Balance (in shares) at Mar. 31, 2021   39,132,307     14,703,214         5,943,014  
Beginning Balance at Dec. 31, 2021 2,310                    
Increase (Decrease) in Temporary Equity                      
Equity Contribution to Consolidated Joint Venture 158                    
Adjustment to Record Noncontrolling Interest at Redemption Value 2,273                    
Net Income (158)                    
Ending Balance at Mar. 31, 2022 4,583                    
Balance at Dec. 31, 2021 608,296   394 0 $ 147 1,155,034 (2,747) (595,454) 557,374 $ 50,922 608,296
Balance (in shares) at Dec. 31, 2021   39,325,025     14,703,214         6,926,253  
Increase (Decrease) in Stockholders' Equity                      
Issuance Costs/Other (39)         (39)     (39)    
Dividends and Distributions declared:                      
Preferred Shares               (6,044) (6,044)   (6,044)
Share Based Compensation:                      
Grants     0           0   0
Grants (in shares)   29,868                  
Amortization           764     764 $ 1,777 2,541
Change in Fair Value of Derivative Instruments 15,489           13,655   13,655 1,834 15,489
Adjustment to Record Noncontrolling Interest at Redemption Value (2,273)         (2,273)     (2,273)    
Net (loss) income (16,966)             (14,242) (14,242) (2,724) (16,966)
Balance at Mar. 31, 2022 $ 601,004   $ 394 $ 0 $ 147 $ 1,153,486 $ 10,908 $ (615,740) $ 549,195 $ 51,809 $ 601,004
Balance (in shares) at Mar. 31, 2022   39,354,893     14,703,214         6,926,253